Wenjian Gan to Molecular Targeted Therapy
This is a "connection" page, showing publications Wenjian Gan has written about Molecular Targeted Therapy.
Connection Strength
0.096
-
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat Med. 2017 Sep; 23(9):1063-1071.
Score: 0.033
-
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer Lett. 2017 01 28; 385:207-214.
Score: 0.032
-
Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Mol Cell. 2016 06 16; 62(6):929-942.
Score: 0.031